Almirall, S.A.
Almirall, S.A.
Explore linked clinical trials.15 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 1 | 2026-10-06 | NCT06928246 | |
| Lebrikizumab in Moderate-to-severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 4 | 2026-09-15 | NCT06906497 | |
| A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-08-17 | NCT07547813 | |
| A Study of Lebrikizumab in Adults With Nummular Eczema | Skin and Connective Tissue Diseases, dermatitis, skin disorder | Recruiting | Phase 3 | 2026-08-17 | NCT07542483 | |
| Study of Alloknesia in Atopic Dermatitis | Alloknesie; Atopic Dermatosis | Recruiting | Not stated | 2026-06-01 | NCT06923202 | |
| A Study of LAD603 in Adults With Alopecia Areata | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 | 2026-05-20 | NCT07311564 | |
| A Study of LAD106 in Healthy Adult Participants | Healthy Volunteers | Recruiting | Phase 1 | 2026-05-15 | NCT07471932 | |
| A Study of LAD191 in Adults With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-05-11 | NCT07151937 | |
| Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 4 | 2026-04-22 | NCT07544251 | |
| A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 3 | 2026-04-21 | NCT06526182 | |
| A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting | Plaque Psoriasis | Active, not recruiting | Not stated | 2025-06-24 | NCT06488170 | |
| A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp | Skin and Connective Tissue Diseases, actinic keratosis, keratosis, neoplasm, precancerous condition, skin disorder | Active, not recruiting | Phase 4 | 2025-02-11 | NCT05387525 | |
| A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Not stated | 2025-02-07 | NCT06815380 | |
| A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Not stated | 2025-01-29 | NCT06030076 | |
| A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Not stated | 2025-01-29 | NCT06029257 |